Sign in
  Edit search
Evaluating guidelines on continuation of anti-tumour necrosi…
Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months%3A clinical effectiveness and costs of observed care and different alternative strategies.
Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months%3A clinical effectiveness and costs of observed care and different alternative strategies.
Article, Chapter
Authors: W. Kievit
Publication: Annals of the Rheumatic Diseases, Volume:68, Issue:6, Page(s):844-849
Published: BMJ Group, 2009
ISSN: 0003-4967
  Full text availability for this item
View Full Text Source:Annals of the Rheumatic Diseases,Annals of the Rheumatic Diseases,BMJ Journals All Titles Opens in new Window
Journal:  Annals of the Rheumatic Diseases Source:BMJ Journals All Titles Opens in new Window
Collection:  BMJ Journals All Titles Opens in new Window
Coverage:
  • 1939~present; volume:1~present;issue:1~present
Browse related articles
  Print copies at your library
Check availability in RUQuest
  Request a copy of this item
Cite this item